Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770–803.
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of america. Clin Infect Dis. 2009;48:1–12.
Imai Y, Meyer KJ, Iinishi A, Favre-Godal Q, Green R, Manuse S, Caboni M, Mori M, Niles S, Ghiglieri M, Honrao C, Ma X, Guo JJ, Makriyannis A, Linares-Otoya L, Böhringer N, Wuisan ZG, Kaur H, Wu R, Mateus A, Typas A, Savitski MM, Espinoza JL, O'Rourke A, Nelson KE, Hiller S, Noinaj N, Schäberle TF, D'Onofrio A, Lewis K. A new antibiotic selectively kills Gram-negative pathogens. Nature 2019;576:459–64.
Lack of new antibiotics threatens global efforts to contain drug-resistant infections. 2020, https://www.who.int/news-room/detail/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections.
Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. 2017, https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12.
Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11:297–308.
Rothe W. The new antibiotic xanthocillin. Dtsch Med Wochenschr. 1954;79:1080–1.
Takatsuki A, Suzuki S, Ando K, Tamura G, Arima K. New antiviral antibiotics; xanthocillin X mono- and dimethylether, and methoxy-xanthocillin X dimethylether. I. Isolation and characterization. (Studies on antiviral and antitumor antibiotics. V). J Antibiot. 1968;21:671–5.
Yamaguchi T, Miyake Y, Miyamura A, Ishiwata N, Tatsuta K. Structure-activity relationships of xanthocillin derivatives as thrombopoietin receptor agonist. J Antibiot. 2006;59:729–34.
Tsunakawa M, Ohkusa N, Kobaru S, Narita Y, Murata S, Sawada Y, Oki T. BU-4704, a new member of the xanthocillin class. J Antibiot. 1993;46:687–8.
Lim FY, Won TH, Raffa N, Baccile JA, Wisecaver J, Rokas A, Schroeder FC, Keller NP. Fungal isocyanide synthases and xanthocillin biosynthesis in Aspergillus fumigatus. Mbio 2018;9:e00785–18.
Itoh J, Takeuchi Y, Gomi S, Inouye S, Mikawa T, Yoshikawa N, Ohkishi H. MK4588, a new antibiotic related to xanthocillin. J Antibiot. 1990;43:456–61.
Isaka M, Boonkhao B, Rachtawee P, Auncharoen P. A xanthocillin-like alkaloid from the insect pathogenic fungus Cordyceps brunnearubra BCC 1395. J Nat Prod. 2007;70:656–8.
Hübner I, Shapiro JA, Hoßmann J, Drechsel J, Hacker SM, Rather PN, Pieper DH, Wuest WM, Sieber SA. Broad spectrum antibiotic xanthocillin X effectively kills Acinetobacter baumannii via dysregulation of heme biosynthesis. ACS Cent Sci. 2021;7:488–98.
West AV, Woo CM. Ironing out new antibiotic mechanisms with Xanthocillin X. ACS Cent Sci. 2021;7:403–5.
Song Y, Yang J, Yu J, Li J, Yuan J, Wong NK, Ju J. Chlorinated bis-indole alkaloids from deep-sea derived Streptomyces sp. SCSIO 11791 with antibacterial and cytotoxic activities. J Antibiot. 2020;73:542–7.
Sun C, Liu Z, Zhu X, Fan Z, Huang X, Wu Q, Zheng X, Qin X, Zhang T, Zhang H, Ju J, Ma J. Antitubercular ilamycins from marine-derived Streptomyces atratus SCSIO ZH16 △ilaR. J Nat Prod. 2020;83:1646–57.
Dong Y, Ding W, Sun C, Ji X, Ling C, Zhou Z, Chen Z, Chen X, Ju J. Julichrome monomers from marine gastropod mollusk-associated Streptomyces and stereochemical revision of julichromes Q3-5 and Q3-3. Chem Biodivers. 2020;17:e2000057.
Luo M, Cui Z, Huang H, Song X, Sun A, Dang Y, Lu L, Ju J. Amino acid conjugated anthraquinones from the marine-derived fungus Penicillium sp. SCSIO sof101. J Nat Prod. 2017;80:1668–73.
Zuck KM, Shipley S, Newman DJ. Induced production of N-formyl alkaloids from Aspergillus fumigatus by co-culture with Streptomyces peucetius. J Nat Prod. 2011;74:1653–7.
Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J. Cyclic hexapeptides from the deep south china sea-derived Streptomyces scopuliridis SCSIO ZJ46 active against pathogenic Gram-positive bacteria. J Nat Prod. 2014;77:1937–41.
CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th ed. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
Ding B, Yuan J, Huang X, Wen W, Zhu X, Liu Y, Li H, Lu Y, He L, Tan H, She Z. New dimeric members of the phomoxanthone family: phomolactonexanthones A, B and deacetylphomoxanthone C isolated from the fungus Phomopsis sp. Mar Drugs. 2013;11:4961–72.
留言 (0)